NASDAQFinancialsInsurance BrokersSnapshot 2026-07-09
Reading LIFE? Create a free portfolio, then add this holding for ongoing Reports and tracking. No credit card.
Create your account →Warn: Management is running behind on a stated commitment.
Ethos aims to reach $563M revenue in 2026. It targets adjusted EBITDA near $105M. The company is addressing recent earnings misses. The stock trades below Street targets, offering potential upside.
Ethos missed earnings recently and faces investor doubts. Profitability remains weak with a net loss in Q1. The stock is under pressure amid a selloff and short reports.
The price is about 14% above our fair value near $17. Our fair value is 37% below the Street median of $27, reflecting skepticism on Ethos's turnaround.
Breaks if: annual revenue falls below $561M in FY26
Ethos aims to achieve its revenue guidance of $561M to $565M for fiscal year 2026.
Stated in 2 of last 2 quarters. Ethos has set a revenue guidance of $561M to $565M for fiscal year 2026. Revenue for 2026-Q1 was $193.1M, indicating a need for significant growth to meet the annual target. The trajectory shows a recurring focus on achieving this guidance.
“For the full fiscal year 2026, Ethos expects the following: Total Revenue: Between $561.0 million and $565.0 million”
“For the full fiscal year 2026, Ethos expects the following: Total Revenue: Between $510.0 million and $514.0 million”
Breaks if: earnings continue to miss guidance in next 2 quarters
Ethos is addressing the earnings miss reported in the recent quarter.
Breaks if: adjusted EBITDA falls below $103M in FY26
Ethos aims to improve its adjusted EBITDA to between $103M and $107M for fiscal year 2026.
Stated in 2 of last 2 quarters. Ethos has set an adjusted EBITDA guidance of $103M to $107M for fiscal year 2026. The focus on improving EBITDA is consistent, but financials show a net income loss of $166.4M in 2026-Q1, indicating limited progress so far.
“For the full fiscal year 2026, Ethos expects the following: Adjusted EBITDA: Between $103.0 million and $107.0 million”
“Adjusted EBITDA: Between $99.0 million and $103.0 million”
Standing thesis, reviewed periodically — not a price target or advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
